These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

235 related articles for article (PubMed ID: 22522403)

  • 41. The comparative effects of telmisartan and ramipril on P-wave dispersion in hypertensive patients: a randomized clinical study.
    Celik T; Iyisoy A; Kursaklioglu H; Yilmaz MI; Kose S; Kilic S; Amasyali B; Demirkol S; Isik E
    Clin Cardiol; 2005 Jun; 28(6):298-302. PubMed ID: 16028466
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Effects of telmisartan and amlodipine in combination on ambulatory blood pressure in stages 1-2 hypertension.
    White WB; Littlejohn TW; Majul CR; Oigman W; Olvera R; Seeber M; Schumacher H; Mancia G
    Blood Press Monit; 2010 Aug; 15(4):205-12. PubMed ID: 20613496
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The efficacy and long-term safety of a triple combination of 80 mg telmisartan, 5 mg amlodipine and 12.5 mg hydrochlorothiazide in Japanese patients with essential hypertension: a randomized, double-blind study with open-label extension.
    Higaki J; Komuro I; Shiki K; Ugai H; Taniguchi A; Ikeda H; Kuroki D; Nishimura S; Ogihara T
    Hypertens Res; 2017 Jan; 40(1):51-60. PubMed ID: 27581533
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Current position of a fixed combination telmisartan with amlodipine in treatment of essential arterial hypertension].
    Slíva J
    Vnitr Lek; 2016; 62(9):699-702. PubMed ID: 27715071
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Efficacy of combination therapy with telmisartan plus amlodipine in patients with poorly controlled hypertension.
    Bekki H; Yamamoto K; Sone M; Homma T; Nakata M; Nohara M; Fukami K; Okuda S; Yamagishi S
    Oxid Med Cell Longev; 2010; 3(5):342-6. PubMed ID: 21150340
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Effectiveness of moxonidine to reduce atrial fibrillation burden in hypertensive patients.
    Deftereos S; Giannopoulos G; Kossyvakis C; Efremidis M; Panagopoulou V; Raisakis K; Kaoukis A; Karageorgiou S; Bouras G; Katsivas A; Pyrgakis V; Stefanadis C
    Am J Cardiol; 2013 Sep; 112(5):684-7. PubMed ID: 23726175
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Renal and vascular protective effects of telmisartan in patients with essential hypertension.
    Morimoto S; Yano Y; Maki K; Sawada K
    Hypertens Res; 2006 Aug; 29(8):567-72. PubMed ID: 17137211
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Single-pill combination of telmisartan/amlodipine versus amlodipine monotherapy in diabetic hypertensive patients: an 8-week randomized, parallel-group, double-blind trial.
    Sharma AM; Bakris G; Neutel JM; Littlejohn TW; Kobe M; Ting N; Ley L
    Clin Ther; 2012 Mar; 34(3):537-51. PubMed ID: 22386829
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Effects of circadian rhythms, posture, and medication on renin-aldosterone interrelations in essential hypertensives.
    Lamarre-Cliche M; de Champlain J; Lacourcière Y; Poirier L; Karas M; Larochelle P
    Am J Hypertens; 2005 Jan; 18(1):56-64. PubMed ID: 15691618
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Treatment of hypertension: postmarketing surveillance study results of telmisartan monotherapy, fixed dose combination of telmisartan + hydrochlorothiazide/amlodipine.
    Arif AF; Kadam GG; Joshi C
    J Indian Med Assoc; 2009 Oct; 107(10):730-3. PubMed ID: 20469750
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The combination of amlodipine and angiotensin receptor blocker or diuretics in high-risk hypertensive patients: rationale, design and baseline characteristics.
    Wang W; Ma L; Zhang Y; Deng Q; Liu M; Liu L
    J Hum Hypertens; 2011 Apr; 25(4):271-7. PubMed ID: 20445570
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Single-pill telmisartan and amlodipine: a rational combination for the treatment of hypertension.
    Suárez C
    Drugs; 2011 Dec; 71(17):2295-305. PubMed ID: 22085386
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Influence of G-protein β-Polypeptide 3 C825T Polymorphism on Antihypertensive Response to Telmisartan and Amlodipine in Chinese Patients.
    Zhang ZL; Li HL; Wen ZP; Yang GP; Zhang W; Chen XP
    Chin Med J (Engl); 2016 Jan; 129(1):8-14. PubMed ID: 26712426
    [TBL] [Abstract][Full Text] [Related]  

  • 54. A comparison study of the echocardiographic changes in hypertensive patients treated with telmisartan vs. enalapril.
    Hadi NR; Abdulzahra MS; Al-Huseini LM; Al-Aubaidy HA
    Int J Cardiol; 2017 Mar; 230():269-274. PubMed ID: 28041700
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Blood pressure in early autosomal dominant polycystic kidney disease.
    Schrier RW; Abebe KZ; Perrone RD; Torres VE; Braun WE; Steinman TI; Winklhofer FT; Brosnahan G; Czarnecki PG; Hogan MC; Miskulin DC; Rahbari-Oskoui FF; Grantham JJ; Harris PC; Flessner MF; Bae KT; Moore CG; Chapman AB;
    N Engl J Med; 2014 Dec; 371(24):2255-66. PubMed ID: 25399733
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Combination of telmisartan plus amlodipine in the treatment of hypertension: review of results.
    Oigman W; Neves MF; Gismondi RA
    Expert Rev Cardiovasc Ther; 2010 Nov; 8(11):1509-17. PubMed ID: 21090924
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Renal outcomes in high-risk hypertensive patients treated with an angiotensin-converting enzyme inhibitor or a calcium channel blocker vs a diuretic: a report from the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT).
    Rahman M; Pressel S; Davis BR; Nwachuku C; Wright JT; Whelton PK; Barzilay J; Batuman V; Eckfeldt JH; Farber M; Henriquez M; Kopyt N; Louis GT; Saklayen M; Stanford C; Walworth C; Ward H; Wiegmann T
    Arch Intern Med; 2005 Apr; 165(8):936-46. PubMed ID: 15851647
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Telmisartan plus hydrochlorothiazide versus telmisartan or hydrochlorothiazide monotherapy in patients with mild to moderate hypertension: a multicenter, randomized, double-blind, placebo-controlled, parallel-group trial.
    McGill JB; Reilly PA
    Clin Ther; 2001 Jun; 23(6):833-50. PubMed ID: 11440284
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Effects of the L/N-Type Ca
    Harada E; Sugino K; Aimoto M; Takahara A
    Biol Pharm Bull; 2021 May; 44(5):707-713. PubMed ID: 33642455
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The effects of telmisartan and amlodipine on metabolic parameters and blood pressure in type 2 diabetic, hypertensive patients.
    Negro R; Hassan H
    J Renin Angiotensin Aldosterone Syst; 2006 Dec; 7(4):243-6. PubMed ID: 17318795
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.